The contrasting opinions on using HPV vaccination for penile cancer eradication is a very interesting topic. Voris et al. noted that "it is recommended vaccination of adolescents (boys and girls) with 11-12 years old, or before the beginning of sexual life (preferably) (1) whereas Ornellas et al. noted that "the male public HPV vaccination is a good measure to prevent not just cervical cancer but some head and neck cancers, some penile warts and the majority of anal cancers. However, it is not clear if it will be enough to eradicate or reduce the prevalence of penile cancer (2). In fact, there are many considerations before the implementation of any new cancer vaccines. Effectiveness and safety are the basic focused concerns. Nevertheless, an additional consideration for using as public health policies that affect mass of populations is usually on the medical economics issue. We would like to share ideas on this issue based on the situation in our setting, a country in Indochina.
